Skip to main content
logo
Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.91
+1.05 (17.92%)
At close: Apr 9, 2026, 4:00 PM EDT
6.91
0.00 (0.00%)
After-hours: Apr 9, 2026, 4:20 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Women's Health Revenue
1.75B1.78B
Women's Health Revenue Growth
-1.41%4.41%
Biosimilars Revenue
691.00M662.00M
Biosimilars Revenue Growth
4.38%11.64%
Established Brands Revenue
3.69B3.85B
Established Brands Revenue Growth
-4.11%0.05%
Other Product Group Revenue
82.00M115.00M
Other Product Group Revenue Growth
-28.70%-4.96%
Revenue (Total)
6.22B6.40B
Revenue (Total) Growth
-2.92%2.23%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States Revenue
1.60B1.57B
United States Revenue Growth
2.04%6.36%
Europe and Canada Revenue
1.62B1.76B
Europe and Canada Revenue Growth
-8.22%5.38%
Asia Pacific and Japan Revenue
1.00B1.05B
Asia Pacific and Japan Revenue Growth
-4.76%-7.00%
China Revenue
829.00M847.00M
China Revenue Growth
-2.13%-1.97%
Latin America, Middle East, Russia and Africa Revenue
1.07B1.03B
Latin America, Middle East, Russia and Africa Revenue Growth
3.67%7.15%
Other International Revenue
93.00M137.00M
Other International Revenue Growth
-32.12%-11.04%
International Revenue
4.61B4.83B
International Revenue Growth
-4.53%0.96%
Revenue (Total)
6.22B6.40B
Revenue (Total) Growth
-2.92%2.23%
Updated Feb 12, 2026. Data Source: Fiscal.ai.